567 related articles for article (PubMed ID: 23396314)
1. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
[TBL] [Abstract][Full Text] [Related]
2. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
3. Monitoring β-arrestin recruitment via β-lactamase enzyme fragment complementation: purification of peptide E as a low-affinity ligand for mammalian bombesin receptors.
Ikeda Y; Kumagai H; Okazaki H; Fujishiro M; Motozawa Y; Nomura S; Takeda N; Toko H; Takimoto E; Akazawa H; Morita H; Suzuki J; Yamazaki T; Komuro I; Yanagisawa M
PLoS One; 2015; 10(6):e0127445. PubMed ID: 26030739
[TBL] [Abstract][Full Text] [Related]
4. High-throughput identification and characterization of novel, species-selective GPR35 agonists.
Neetoo-Isseljee Z; MacKenzie AE; Southern C; Jerman J; McIver EG; Harries N; Taylor DL; Milligan G
J Pharmacol Exp Ther; 2013 Mar; 344(3):568-78. PubMed ID: 23262279
[TBL] [Abstract][Full Text] [Related]
5. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.
Yin H; Chu A; Li W; Wang B; Shelton F; Otero F; Nguyen DG; Caldwell JS; Chen YA
J Biol Chem; 2009 May; 284(18):12328-38. PubMed ID: 19286662
[TBL] [Abstract][Full Text] [Related]
6. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
7. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
[TBL] [Abstract][Full Text] [Related]
9. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling.
Emery AC; DiRaddo JO; Miller E; Hathaway HA; Pshenichkin S; Takoudjou GR; Grajkowska E; Yasuda RP; Wolfe BB; Wroblewski JT
Mol Pharmacol; 2012 Aug; 82(2):291-301. PubMed ID: 22584219
[TBL] [Abstract][Full Text] [Related]
10. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
[TBL] [Abstract][Full Text] [Related]
11. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors.
Evans NA; Groarke DA; Warrack J; Greenwood CJ; Dodgson K; Milligan G; Wilson S
J Neurochem; 2001 Apr; 77(2):476-85. PubMed ID: 11299310
[TBL] [Abstract][Full Text] [Related]
12. Monitoring G protein-coupled receptor activation using an adenovirus-based β-arrestin bimolecular fluorescence complementation assay.
Song YB; Park CO; Jeong JY; Huh WK
Anal Biochem; 2014 Mar; 449():32-41. PubMed ID: 24361713
[TBL] [Abstract][Full Text] [Related]
13. A novel luminescence-based β-arrestin recruitment assay for unmodified receptors.
Hauge Pedersen M; Pham J; Mancebo H; Inoue A; Asher WB; Javitch JA
J Biol Chem; 2021; 296():100503. PubMed ID: 33684444
[TBL] [Abstract][Full Text] [Related]
14. Discovery of β-arrestin-biased β
Woo AY; Ge XY; Pan L; Xing G; Mo YM; Xing RJ; Li XR; Zhang YY; Wainer IW; Cheng MS; Xiao RP
Acta Pharmacol Sin; 2019 Aug; 40(8):1095-1105. PubMed ID: 30643208
[TBL] [Abstract][Full Text] [Related]
15. Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.
Soethoudt M; van Gils N; van der Stelt M; Heitman LH
Methods Mol Biol; 2016; 1412():103-11. PubMed ID: 27245896
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
[TBL] [Abstract][Full Text] [Related]
17. A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation.
Barak LS; Ferguson SS; Zhang J; Caron MG
J Biol Chem; 1997 Oct; 272(44):27497-500. PubMed ID: 9346876
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Orphan G Protein-Coupled Receptor GPR27 by Surrogate Ligands Promotes
Dupuis N; Laschet C; Franssen D; Szpakowska M; Gilissen J; Geubelle P; Soni A; Parent AS; Pirotte B; Chevigné A; Twizere JC; Hanson J
Mol Pharmacol; 2017 Jun; 91(6):595-608. PubMed ID: 28314853
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
